Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav in Russian Glaucoma Patients
NCT01696383Phase 4Withdrawn
- Sponsor
- Alcon Inc.
- Start
- Feb 2013
- Primary completion
- Feb 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 4 trial of travoprost, timolol maleate gel + placebo in Open-angle glaucoma (OAG), ocular hypertension, Glaucoma, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Planned start Feb 2013; status: withdrawn.
02
Drugs
travoprosttimolol maleate gel + placebo
03
Conditions
Open-angle glaucoma (OAG)ocular hypertensionGlaucomapigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT01696383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696383.